Origen de la red de primer grado Paul Magrez.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
74
| Public Company | Pharmaceuticals: Major | 74 |
16
| Extinct | Pharmaceuticals: Major | 16 |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium.
9
| Subsidiary | Medical Specialties | 9 |
Fund+
 Fund+ Investment ManagersFinance Fund+ is an independent Venture Capital firm founded in 2015. The firm is headquartered in Leuven, Belgium.
4
| Private Company | Investment Managers | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Paul Magrez a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | General Counsel Chief Tech/Sci/R&D Officer | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Chairman Director of Finance/CFO Chief Tech/Sci/R&D Officer Director/Board Member | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| VERNALIS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
DSM NV
 DSM NV Chemicals: SpecialtyProcess Industries DSM BV engages in the provision of ingredients, expertise, and solutions for plant-based products. It operates through the following segments: Animal Nutrition and Health (ANH); Health, Nutrition, and Care (HNC); Food and Beverage (F and B); and Other. The ANH segment includes developing sustainable animal farming through essential products, performance solutions, and precision services serving the poultry, swine, ruminants, and aquaculture markets. The HNC segment provides health, nutrition, and care solutions for markets such as early life nutrition, dietary supplements, pharma, medical, and personal care. The F and B segment focuses on supporting healthy diets through nutritious, delicious, and sustainable solutions for several market segments including bakery, beverages and brewing, dairy, savory, plant-based alternative proteins, and pet food. The Other segment is involved in corporate activities. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands. | Chemicals: Specialty | Public Communications Contact Public Communications Contact | |
| RENEURON GROUP PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TIGENIX NV | Medical Specialties | Chairman Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Private Equity Investor Corporate Officer/Principal President | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| Stanford University | College/University | Graduate Degree Masters Business Admin | |
| DECHRA PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
| University of Oxford | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| The University of Manchester | College/University | Undergraduate Degree Doctorate Degree | |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Corporate Officer/Principal Chairman Corporate Officer/Principal | |
| University of Cambridge | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
Andera Partners SCA
 Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor Private Equity Investor | |
| The University of Southampton | College/University | Doctorate Degree Doctorate Degree | |
| Queen's University of Belfast | College/University | Undergraduate Degree Undergraduate Degree | |
| University of London | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Chief Tech/Sci/R&D Officer Doctorate Degree | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Solvay Pharmaceuticals SA
 Solvay Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Solvay Pharmaceuticals SA develops, manufactures, and supplies pharmaceutical products. The company's products include cardio-metabolics, influenza vaccines, adjuvants, and women's and men's healthcare products. It offers fenofibrate, a cardio-metabolic product for treating raised blood lipids and dyslipidemia products that control cholesterol and triglycerides. The firm is headquartered in Brussels, France. | Pharmaceuticals: Major | Chief Executive Officer Public Communications Contact | |
Bio-Incubator Leuven
 Bio-Incubator Leuven Real Estate DevelopmentFinance Bio-Incubator Leuven is a dynamic and innovative environment that provides lab space and support to R&D-intensive life sciences companies. The private company offers customizable modules that can be modified to meet the specific requirements of each client. The company is based in Leuven, Belgium. Leuven's knowledge institutes, including KU Leuven, University Hospitals Leuven, VIB, and IMEC, generate a huge outflow of knowledge that entails a myriad of innovative ideas for new and existing companies. The CEO of the Belgian company is Michaël de Blauwe. | Real Estate Development | Director/Board Member Director/Board Member | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
Union Wallonne des Entreprises
 Union Wallonne des Entreprises Miscellaneous Commercial ServicesCommercial Services Union Wallonne des Entreprises (UWE) is an organization of private employers that aims to accelerate the creation and development of economic activity in historic Wallonia. UWE is based in Wavre, Belgium. UWE comprises thematic commissions, sectoral federations, and associated member companies. The organization provides an extranet for its members, publishes an agenda, and releases position papers. | Miscellaneous Commercial Services | President Director/Board Member | |
BNP Paribas Fortis SA/NV (Broker)
 BNP Paribas Fortis SA/NV (Broker) Investment Banks/BrokersFinance BNP Paribas Fortis SA/NV (Broker) (BNP Paribas Fortis-Broker) is the securities brokerage division of BNP Paribas Fortis SA/NV (EBR:1153319), an international bank headquartered in Brussels, Belgium. The firm was founded in 1990 and is owned by BNP Paribas SA (EPA: BNP, ADR: BNPQY) in France. BNP Paribas Fortis-Broker provides brokerage services to various clients. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Antwerp | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
| The University of North Carolina at Charlotte | College/University | Corporate Officer/Principal Doctorate Degree | |
| Magenta Tree BV | Corporate Officer/Principal Founder | ||
| INVENTIVA | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Sise SA | Director/Board Member Director/Board Member | ||
Gammadelta Therapeutics Ltd.
 Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
Indigo Diabetes NV
 Indigo Diabetes NV Medical SpecialtiesHealth Technology Indigo Diabetes NV develops a needle-free glucose sensor by exploiting groundbreaking photonics technology. Its product addresses the need for accurate, low-cost glucose monitoring systems with an optimal user experience. The company was founded by Danae Delbeke on November 17, 2016 and is headquartered in Ghent, Belgium. | Medical Specialties | Director/Board Member Director/Board Member | |
Synergia Medical SA
 Synergia Medical SA Packaged SoftwareTechnology Services Synergia Medical SA operates as a optoelectronics for neurostimulation medical devices. The company was founded by Attila Borbath and Pascal Doguet on September 26, 2013 and is headquartered in Mont-Saint-Guibert, Belgium. | Packaged Software | Director/Board Member Chairman | |
| IMMUNIC, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| HYLORIS PHARMACEUTICALS SA | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Smithkline Beecham Pharmaceuticals (Canada) | Corporate Officer/Principal Sales & Marketing |
Estadísticas
Internacional
| Estados Unidos | 17 |
| Bélgica | 14 |
| Reino Unido | 13 |
| Francia | 4 |
| Suiza | 3 |
Sectorial
| Health Technology | 25 |
| Consumer Services | 14 |
| Finance | 5 |
| Commercial Services | 3 |
| Process Industries | 2 |
Operativa
| Director/Board Member | 484 |
| Corporate Officer/Principal | 261 |
| Independent Dir/Board Member | 119 |
| Chairman | 115 |
| Chief Tech/Sci/R&D Officer | 90 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Argeris Karabelas | 42 |
| Tamar Howson | 41 |
| Chris Buyse | 39 |
| Elaine Jones | 37 |
| Baron Jean Stéphenne | 36 |
| David Lawrence | 29 |
| Tim Tyson | 28 |
| Jean-Pierre Garnier | 28 |
| Robert Ruffolo | 24 |
| Dean Mitchell | 22 |
| Frank Morich | 21 |
| David Wheadon | 21 |
| Damian Marron | 21 |
| Ian Gilham | 20 |
| Michael Owen | 20 |
- Bolsa de valores
- Insiders
- Paul Magrez
- Conexiones Empresas
